372 related articles for article (PubMed ID: 3005521)
1. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Cersosimo RJ; Hong WK
J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
[TBL] [Abstract][Full Text] [Related]
2. 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
Ganzina F
Cancer Treat Rev; 1983 Mar; 10(1):1-22. PubMed ID: 6342772
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin in advanced gastrointestinal (GI) cancer.
Wils JA
Onkologie; 1986 Aug; 9 Suppl 1():21-3. PubMed ID: 3018649
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in prevention of the recurrence of resectable cancer.
Bonadonna G; Tancini G; Rossi A; Gasparini M
Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
[No Abstract] [Full Text] [Related]
5. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
Seymour L; Bramwell V; Moran LA
Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
[TBL] [Abstract][Full Text] [Related]
6. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
Holdener EE; Hansen HH; Høst H; Bruntsch U; Cavalli F; Renard J; Pinedo HM; Rozencweig M
Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
Case DC; Gams R; Ervin TJ; Boyd MA; Oldham FB
Cancer Res; 1987 Dec; 47(23):6393-6. PubMed ID: 3479245
[TBL] [Abstract][Full Text] [Related]
9. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
Sinkule JA
Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Goldin A; Venditti JM; Geran R
Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
[TBL] [Abstract][Full Text] [Related]
11. [Epirubicin (4'-epi-adriamycin].
Tsukagoshi S
Gan To Kagaku Ryoho; 1990 Jan; 17(1):151-9. PubMed ID: 2404456
[TBL] [Abstract][Full Text] [Related]
12. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of epirubicin in advanced lung cancer].
Furuse K; Fukuoka M; Yamamoto M; Kawahara M; Tsuruta M; Kodama N; Arai R; Hayashi S; Kiyota M; Kubota K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin (Mutamycin).
Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
[No Abstract] [Full Text] [Related]
15. Phase I study of epirubicin given on a weekly schedule.
Snyder R; Bishop J; Brodie G; Burns W; Coates A; Levi J; Raghavan D; Schwarz M; Tattersall M; Thomson D
Cancer Treat Rep; 1987 Mar; 71(3):273-6. PubMed ID: 3028619
[TBL] [Abstract][Full Text] [Related]
16. Curative cancer chemotherapy.
Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
[TBL] [Abstract][Full Text] [Related]
17. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
[No Abstract] [Full Text] [Related]
18. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Hurteloup P; Ganzina F
Drugs Exp Clin Res; 1986; 12(1-3):233-46. PubMed ID: 3525075
[TBL] [Abstract][Full Text] [Related]
19. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.
Plosker GL; Faulds D
Drugs; 1993 May; 45(5):788-856. PubMed ID: 7686469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]